Compare
Abbott Laboratories vs Teleflex (ABT vs TFX)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.6% and Teleflex (TFX) +42.6%; so far this year the figures are -11.8% and +26.8%.
Abbott Laboratories is the larger company by market value, about 31.2 times the size of Teleflex.
On trailing earnings, ABT trades at 41.1 times and TFX at 18.8 times.
Revenue grew +10.0% at ABT and +20.9% at TFX over the last year.
ABT yields 2.28%. TFX yields 0.88%.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | TFX | |
|---|---|---|
| Price | $110.51 | $154.73 |
| 1-day | +0.53% | +2.56% |
| YTD | -11.80% | +26.79% |
| 1 year | -11.56% | +42.60% |
| 3 years | +15.16% | -26.03% |
| Market cap | $191.4B | $6.1B |
| P/E | 41.1 | 18.8 |
| P/S | 3.97 | 2.72 |
| P/B | 3.75 | 1.76 |
| Revenue growth | +10.00% | +20.90% |
| EPS growth | -66.20% | — |
| Gross margin % | 56.9 | 58.3 |
| Net margin % | 9.7 | 13.5 |
| ROE % | 9.2 | 8.7 |
| Debt / equity | 0.61 | 0.46 |
| FCF yield % | 3.5 | 4.0 |
| Dividend yield % | 2.28 | 0.88 |
| Beta | 0.07 | 0.51 |
| RSI (14) | 59.4 | 79.2 |
| Technical rating |